Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis

Bibliographic Details
Main Authors: BMY Cheung, Y Fei, MF Tsoi
Format: Article
Language:English
Published: Radcliffe Medical Media 2020-05-01
Series:European Cardiology Review
Online Access:https://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO17
_version_ 1797200148924727296
author BMY Cheung
Y Fei
MF Tsoi
author_facet BMY Cheung
Y Fei
MF Tsoi
author_sort BMY Cheung
collection DOAJ
first_indexed 2024-03-07T17:41:26Z
format Article
id doaj.art-dd9be6f92db7431eb3c2fdcd618939ad
institution Directory Open Access Journal
issn 1758-3756
1758-3764
language English
last_indexed 2024-04-24T07:27:03Z
publishDate 2020-05-01
publisher Radcliffe Medical Media
record_format Article
series European Cardiology Review
spelling doaj.art-dd9be6f92db7431eb3c2fdcd618939ad2024-04-20T16:01:46ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642020-05-0115e4010.15420/ecr.2020.15.1.PO17Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysisBMY Cheung0Y Fei1MF Tsoi2Hong KongHong KongHong Konghttps://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO17
spellingShingle BMY Cheung
Y Fei
MF Tsoi
Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
European Cardiology Review
title Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
title_full Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
title_fullStr Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
title_full_unstemmed Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
title_short Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
title_sort cardiovascular benefits of new antidiabetic drug classes a network meta analysis
url https://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO17
work_keys_str_mv AT bmycheung cardiovascularbenefitsofnewantidiabeticdrugclassesanetworkmetaanalysis
AT yfei cardiovascularbenefitsofnewantidiabeticdrugclassesanetworkmetaanalysis
AT mftsoi cardiovascularbenefitsofnewantidiabeticdrugclassesanetworkmetaanalysis